Intellicell Biosciences Inc (fka SVFC)

[Investorr]

SVFC Slideshow Highlights:
http://proactivecapital.com/wp-content/uploads/2013/02/intellicellInvestorPP.pdf

-New Flagship Facility on Park Ave, NY, with projected revenue $10-12 million
-Starts slowly at 2 facilities added per year, ramps to over 10 per year
-By 5th year 40 remote facilities bring Total Revenue over $220M

Performance Details
-Each New Facility incurs a one-time $800k acquisition and startup cost
-Each New Facility yields $6.4M annual revenue with $3.2M annual profit
-Total 5th year expenses of $117M yield Gross Profit of $106M
-Profitable all 5 years with increasing Gross Margin from 18% to 47%

IntelliCell Partners:
-Andrews Orthopedic Center
-Rutgers
-NYU Langone Medical Center
-Winthrop University Hospital
-UCL
-Biologics
-EMD Millipore (a Division of Merck)
-Buchanan Ingersoll
-University of Florida
-Sichenzia Ross Friedman Ference
-Numoda

$SVFC